Paracetamol B. Braun (Paracetamol)

Paracetamol works by inhibiting the synthesis of prostaglandins in the central nervous system, primarily through blockade of cyclooxygenase enzymes. This reduces the formation of pain‑inducing and fever‑inducing mediators, leading to decreased nociceptive signaling and a lowered hypothalamic set‑point for body temperature.

The appropriate dose of Paracetamol B. Braun is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and overall treatment plan. Healthcare professionals follow local guidelines and product labeling to calculate the exact amount required for each individual case.

Safety data for intravenous paracetamol during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should evaluate each case carefully and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain handling if needed), and any required import documentation.

Compared with other intravenous analgesics such as ibuprofen or ketorolac, paracetamol offers effective pain relief and fever reduction with a lower risk of gastrointestinal irritation and platelet dysfunction. However, it lacks significant anti‑inflammatory activity, and its safety profile requires careful monitoring of liver function, especially in patients with pre‑existing hepatic disease.

Paracetamol B. Braun should be stored at 2‑8 °C (refrigerated), protected from light, and must not be frozen or shaken. The solution should be kept in its original container until use, and any unused portion should be discarded according to local regulations after the recommended in‑use period.

The product is administered intravenously by a healthcare professional. It is typically diluted in an appropriate compatible IV fluid and infused over a short period, following the dosage instructions provided by the prescriber and the product’s labeling. Administration should be performed under aseptic conditions.

The most serious risks include hepatotoxicity, which can lead to severe liver injury, especially with overdose or in patients with existing liver disease, and rare allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt recognition of these events and immediate medical intervention are essential.

Paracetamol B. Braun should be avoided in individuals with known hypersensitivity to paracetamol or any of its excipients, and in patients with severe hepatic impairment or active liver disease. Caution is also advised for patients taking multiple hepatotoxic medications or those with a history of severe allergic reactions.